NCT01539317View on ClinicalTrials.gov

Therapy to Prevent Sexual Pain in Breast Cancer Survivors

PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
VulvodyniaDyspareuniaBreast CancerMenopause
Interventions
DRUG

Topical liquid lidocaine

active intervention drug numbs the hypersensitive mucosa of the vulvar vestibule

DRUG

Topical saline

saline applied to the vestibule mucosa will not reverse the local tenderness

Trial Locations (1)

97239

Oregon Health & Science University, Portland

All Listed Sponsors
lead

OHSU Knight Cancer Institute

OTHER

NCT01539317 - Therapy to Prevent Sexual Pain in Breast Cancer Survivors | Biotech Hunter | Biotech Hunter